When a hepatic cyst becomes infected, it requires prompt recognition and a structured antibiotic treatment approach. The diagnosis is established by integrating clinical signs of infection with supporting laboratory and imaging findings.
This protocol applies to patients with a hepatic cyst complicated by infection. Diagnosis should be considered in any patient presenting with clinical signs of infection alongside supportive laboratory and imaging evidence.
Management is initiated with empirical antibiotic therapy targeting the most likely organisms. The specific antibiotic selection, combination strategy, and course are defined in the full protocol.
The primary goal is resolution of fever. Response at 48 hours is a key clinical decision point — the full protocol specifies the pathway when this target is not met.
The diagnosis of hepatic cyst infection should be considered in patients who present with clinical signs of infection alongside supportive laboratory and imaging findings (Table 2).
Since E. coli is the most common strain in infected hepatic cysts, ciprofloxacin and/or 3rd generation cephalosporin alone or combination therapy are recommended empirically as the first antibiotic to be tried.
Empirical antibiotic use for about 4–6 weeks is recommended.
If the temperature persists above 38.5 degrees even after 48 hours of empiric antibiotic use, resistance to antibiotics is confirmed in culture, or there is a problem with the patient's immune system, drainage procedures should be actively considered.
View source ↗